南非住院人类免疫缺陷病毒(HIV)感染者中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)高病毒载量持续排毒时间延长
2020年5月至12月在南非20家医院开展前瞻性队列研究,纳入300例住院有症状COVID-19成人,每2天采集鼻咽/口咽拭子至连续2次阴性。257例(155例HIV未感染、102例HIV感染者)中,排毒停止中位时间13天(IQR 6-25),按HIV感染状态无显著差异;在初始Ct值<30的94例亚组中,CD4计数<200 cells/µL的HIV感染者高病毒载量排毒时间中位27天(IQR 8-43),显著长于HIV未感染者的7天(IQR 4-13)(aHR 0.14,95%CI .07-.28,P<.001)。
要点
- 住院COVID-19患者排毒停止中位时间13天(IQR 6-25),按HIV感染状态无显著差异。
- 初始Ct值<30亚组中,CD4<200 cells/µL的HIV感染者高病毒载量排毒中位27天,HIV未感染者为7天(aHR 0.14,P<.001)。
- HIV未抑制者高病毒载量排毒时间也长于HIV未感染者。
核心结论
- SARS-CoV-2排毒持续时间按HIV感染状态无显著差异,但在初始高病毒载量亚组中,免疫抑制的HIV感染者高病毒载量排毒时间长于HIV未感染者。
- 更好的HIV控制可能缩短SARS-CoV-2传播时间。
研究设计与样本
- 2020年5月至12月在南非20家医院开展前瞻性队列研究。
- 筛查2175例COVID-19患者,纳入300例住院有症状COVID-19成人,每2天采集鼻咽/口咽拭子至连续2次阴性确认排毒停止。
- 257例(155例HIV未感染、102例HIV感染者)有>1次拭子采集访视(中位5次,范围2-21)。
- 采用实时逆转录聚合酶链反应检测SARS-CoV-2,Ct值<30视为高SARS-CoV-2病毒载量的替代指标。
- 采用加速时间失败Weibull回归模型评估与排毒时间延长相关的因素。
主要发现
- 排毒停止中位时间为13天(IQR 6-25),按HIV感染状态无显著差异。
- 94例初始呼吸道样本Ct值<30的亚组(41例HIV感染者、53例HIV未感染者)中,高SARS-CoV-2病毒载量排毒中位时间为8天(IQR 4-17)。
- CD4计数<200 cells/µL的HIV感染者高病毒载量排毒中位27天(IQR 8-43),HIV未感染者为7天(IQR 4-13),aHR 0.14(95%CI .07-.28,P<.001)。
- HIV未抑制者高病毒载量排毒时间也长于HIV未感染者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding duration and magnitude among persons living with human immunodeficiency virus (HIV, PLHIV). METHODS: From May through December 2020, we conducted a prospective cohort study at 20 hospitals in South Africa. Adults hospitalized with symptomatic coronavirus disease 2019 (COVID-19) were enrolled and followed every 2 days with nasopharyngeal/oropharyngeal (NP/OP) swabs until documentation of cessation of SARS-CoV-2 shedding (2 consecutive negative NP/OP swabs). Real-time reverse transcription-polymerase chain reaction testing for SARS-CoV-2 was performed, and cycle-threshold (Ct) values < 30 were considered a proxy for high SARS-CoV-2 viral load. Factors associated with prolonged shedding were assessed using accelerated time-failure Weibull regression models. RESULTS: Of 2175 COVID-19 patients screened, 300 were enrolled, and 257 individuals (155 HIV-uninfected and 102 PLHIV) had > 1 swabbing visit (median 5 visits [range 2-21]). Median time to cessation of shedding was 13 days (interquartile range [IQR] 6-25) and did not differ significantly by HIV infection. Among a subset of 94 patients (41 PLHIV and 53 HIV-uninfected) with initial respiratory sample Ct-value < 30, median time of shedding at high SARS-CoV-2 viral load was 8 days (IQR 4-17). This was significantly longer in PLHIV with CD4 count < 200 cells/µL, compared to HIV-uninfected persons (median 27 days [IQR 8-43] vs 7 days [IQR 4-13]; adjusted hazard ratio [aHR] 0.14, 95% confidence interval [CI] .07-.28, P < .001), as well as in unsuppressed-HIV versus HIV-uninfected persons. CONCLUSIONS: Although SARS-CoV-2 shedding duration did not differ significantly by HIV infection, among a subset with high initial SARS-CoV-2 viral loads, immunocompromised PLHIV shed SARS-CoV-2 at high viral loads for longer than HIV-uninfected persons. Better HIV control may potentially decrease transmission time of SARS-CoV-2.
引用
- Meiring S, Tempia S, Bhiman JN, et al. Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa. Clin Infect Dis. 2022. PMID: 35134129. doi:10.1093/cid/ciac077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。